• NSCLC3

• Protocols

• UW21051

  OPEN TO ACCRUAL

  Phase 1/2 Study LY3537982 in pts w/KRAS G12-C-Mutant Advanced Solid Tumors
  
  

• UW21074

  OPEN TO ACCRUAL

  Phase 1 of TJ033721 in Advanced or Metastatic Solid Tumors
  
  

• UW22127

  OPEN TO ACCRUAL

  PH1 Study of GD2-SADA:177Lu-DOTA in pts w/GD2 Recurrent or Refractory Metastatic Solid Tumors